Trial Profile
Tolerability of single ascending doses of silodosin in Chinese male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2011
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Benign prostatic hyperplasia; Dysuria; Nocturia; Prostatitis; Urinary calculi
- Focus Adverse reactions
- 06 Sep 2011 New trial record
- 01 Aug 2011 Results published in the Biological and Pharmaceutical Bulletin.